NHS England announces PrEP trial
NHS England have today announced that they will fund a PrEP (pre-exposure prophylaxis) trial for HIV prevention. It is anticipated that the trial will include at least 10,000 participants over the next three years.
Ian Green, Chief Executive of Terrence Higgins Trust, said:
“With 17 new HIV diagnoses made every day, we need to be bold and ambitious in our approach to HIV prevention - and this must include access to PrEP for all who need it.
“For two years we’ve been calling for a long-term, stable home for PrEP within the NHS, so it can be used as a vital tool in our HIV prevention armoury alongside condom use, regular testing and early treatment.
“We welcome the fact that PrEP will be made available to 10,000 people who are at risk over three years. Preventing the spread of HIV is good news for everyone. Not only will this make a life-changing difference to each of these individuals by protecting them from an incurable and highly stigmatised condition, but for every person who would have become HIV positive without PrEP, the NHS will save £360,000 in lifetime treatment costs.
“However there are many questions that need to be answered about the proposed trial. We need to know how it will work in practice and understand how those at risk, no matter where they live, will be able to access PrEP.
“This trial alone does not provide the long-term stability that is needed – NHS England must make a commitment now that when the trial ends they will fully fund PrEP for all those who are at risk. Only then can we look forward to a future without HIV transmissions, which would be a stunning achievement in terms of public health.”
Find out more about PrEP.